Real World CCH Study in Adult Females With Cellulite
Public ClinicalTrials.gov record NCT04170296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Real World, Multicenter, Open-Label, Multiple Dose Study to Assess the Effectiveness of, and Satisfaction With, CCH Treatment of Buttocks or Thigh Cellulite in Adult Females
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, open-label, multiple dose, 2 cohort, Phase 3b study to assess the safety and efficacy of CCH in adult women with mild or moderate edematous fibrosclerotic panniculopathy (EFP). Cohort 1 will include approximately 80 subjects with mild or moderate EFP in the posterolateral thighs and Cohort 2 will include approximately 70 subjects with mild or moderate EFP in the buttocks.
Study identification
- NCT ID
- NCT04170296
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 153 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2019
- Primary completion
- Oct 5, 2020
- Completion
- Jan 7, 2021
- Last update posted
- Feb 21, 2022
2019 – 2021
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Clinical Trial Site #2 | Encino | California | 91436 | — |
| Endo Clinical Trial Site #4 | San Diego | California | 92121 | — |
| Endo Clinical Trial Site #5 | Solana Beach | California | 92075 | — |
| Endo Clinical Trial Site #9 | Westport | Connecticut | 00688 | — |
| Endo Clinical Trial Site #1 | Coral Gables | Florida | 33146 | — |
| Endo Clinical Trial Site #10 | Alpharetta | Georgia | 30005 | — |
| Endo Clinical Trial Site #3 | Chicago | Illinois | 60611 | — |
| Endo Clinical Trial Site #11 | Itasca | Illinois | 60143 | — |
| Endo Clinical Trial Site #8 | New Orleans | Louisiana | 70130 | — |
| Endo Clinical Trial Site #6 | New York | New York | 10021 | — |
| Endo Clinical Trial Site #12 | Nashville | Tennessee | 37215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04170296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2022 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04170296 live on ClinicalTrials.gov.